When viruses travel through the air in tiny droplets, they can quickly start to dry out. Yet many viruses remain infectious after rehydration—something that is still not fully understood. Now, an ...

The 2026 Tesla Model 3 compact electric sedan still heads its class, almost a decade after its launch. This is partly down to four reasons: judicious updates that culminated in the major Highland 2024 ...

Stability AI, the company behind Stable Diffusion, is releasing a new family of audio models, called Stability Audio 3.0. The top model can generate professional-grade music of more than six minutes ...

Shell's CEO used a specific phrase on the earnings call that captures how serious the global oil supply situation has become. The shortage Sawan described has an unusual characteristic that means it ...

Microsoft Corp. aims to develop large, cutting-edge artificial intelligence models by next year, part of a push to build in-house alternatives to the most powerful AI tools from OpenAI and Anthropic. ...

Tesla is ending production of its Model S and Model X electric vehicles. CEO Elon Musk announced the company will shift focus to building robots and autonomous vehicles. Customers can still purchase ...

What does a Tesla Model Y actually cost per mile? I break down electricity, depreciation, insurance, maintenance, and tires to give you the real number. The 2026 Model Y gets roughly 4 miles per ...

Competition in the world of business is a good thing for the consumer, right? It keeps prices down and forces innovation. Well, the motor oil space isn't as competitive as you might have thought. For ...

Google-spinoff Waymo is in the midst of expanding its self-driving car fleet into new regions. Waymo touts more than 200 million miles of driving that informs how the vehicles navigate roads, but the ...

This past summer, Google DeepMind debuted Genie 3. It's what's known as a world world, an AI system capable of generating images and reacting as the user moves through the environment the software is ...

Beam Therapeutics BEAM is engaged in developing investigational gene therapy candidates that are currently in early-to-mid-stage development for treating certain hematology and genetic diseases. The ...